Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 18 and up

Self-balancing exoskeleton to support rehabilitation after thoracic surgery

Official title: Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial

Run by Wandercraft · NCT07220733 · Data updated 2026-11-12

This trial will test whether a wearable self-balancing exoskeleton (Atalante X) can help adults recovering from thoracic surgery stand and walk more safely in the ICU.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment5 (estimated)
SponsorWandercraft
Industry-sponsored
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedOctober 2025
Main results expectedFebruary 2026
Study endsFebruary 2026
Registry record updatedOctober 24, 2025
Trial IDNCT07220733 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) admitted to the Thoracic Surgical ICU after thoracic surgery who are debilitated (JH-HLM score ≤ 5) and who meet the device size and medical safety criteria are ideal candidates.

Probably not a fit

Patients with disqualifying conditions such as severe lower-extremity spasticity, recent unstable cardiac events, unhealed fractures, severe osteoporosis, significant skin breakdown at contact sites, or those outside the device height/weight limits are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm pilot conducted in the Thoracic Surgical ICU at Brigham and Women's Hospital using the Atalante X self-balancing robotic exoskeleton. Eligible adult patients who are debilitated after thoracic surgery (JH-HLM ≤ 5) will receive individualized exoskeleton sessions up to 2–3 times per week for a maximum of two weeks, with progressive standing and walking as tolerated. The study will focus on safety and feasibility outcomes, monitoring vital signs, device tolerability, and any adverse events while documenting mobility gains and staff assistance requirements. Results will inform whether this device can be integrated into early ICU rehabilitation workflows.

Why it matters

Potential benefit: If successful, this approach could help patients stand and walk earlier after thoracic surgery, reduce complications related to immobility, and lessen the physical burden on staff.

How similar studies have gone: Previous clinical work with the Atalante X in spinal cord injury and post-stroke populations demonstrated safety and feasibility with mobility gains, but its use in the immediate postoperative ICU setting is a novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Above age of 18 years old,
* Having undergone thoracic surgery that necessitated admission in the TSICU.
* Debilitated as defined as a JH-HLM score of 5 or less

Exclusion Criteria:

* Height \< 6'3 feet or weight \> 220 lbs restrictions
* Severe muscular spasticity of the lower extremities (Modified Ashworth Scale Grade 3 higher).
* Current fractures or incomplete bone junctions in the spine, pelvis, and/or lower extremities
* Osteoporosis or lower bone mineral density -3.5, and history(ies) of osteoporotic fracture(s).
* Skin disorders including Stage I pressure injuries at the hip, lower limbs, and Exoskeleton contact areas, according to the National and European Pressure Ulcer Classification System (NPUAP-EPUAP).
* Severe arthritis, acute arthritis, or synovitis after total or partial lower limb joint replacement.
* Myocardial infarction or angina or ischemic heart disease within the last 6 months.
* Uncorrectable leg length discrepancy over 2 cm when using additional correction tools.
* III-IV spine scoliotic deformity.
* Amputations and lower limb prostheses.
* Pregnancy
* Adults who lack the capacity to provide informed consent
* Cardiovascular instability as indicated by:
* Presence of unstable ventricular or atrial arrhythmias
* HR \< 40 or HR \> 140
* Lactate \> 4.0 mmol/L
* On moderate-high dose vasopressors/inotropes
* Currently on VA ECMO
* Respiratory instability as indicated by:
* FiO2 \> 0.6
* PEEP \> 12 cm H2O
* RR \> 35 bpm
* Currently on VV-ECMO
* Unable to follow commands
* Has bed rest orders

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.